Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00968227 · ClinicalTrials.gov registry record · Phase 1
Effect of Red Blood Cell Transfusion on Brain Metabolism in Patients With Subarachnoid Hemorrhage
A Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
NCT00968227 is a Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 56 participants.
The verdict
NCT00968227, a Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if giving blood transfusions to anemic patients with subarachnoid hemorrhage will reduce their chances of having a stroke from vasospasm.
Interventions
- BIOLOGICAL Red blood cell transfusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2007-11 |
| Est. Completion | 2015-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00968227
The ClinicalTrials.gov registry entry for NCT00968227 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Red blood cell transfusion is the first listed.
NCT00968227 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00968227 about?
NCT00968227 is a clinical study titled "Effect of Red Blood Cell Transfusion on Brain Metabolism in Patients With Subarachnoid Hemorrhage". The purpose of this study is to determine if giving blood transfusions to anemic patients with subarachnoid hemorrhage will reduce their chances of having a stroke from vasospasm.
What is the current status of trial NCT00968227?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2007-11. Estimated completion is 2015-08.
What interventions are being tested in trial NCT00968227?
The interventions under investigation include: Red blood cell transfusion (BIOLOGICAL).
Who is sponsoring clinical trial NCT00968227?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.